Skip to main content

Find Clinical Trials

Home
Conditions
Myelodysplastic Syndromes

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

268 public trials 58 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer

NCT00312429

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +22 more
Locations: Duke University Durham, North Carolina, United States

View Trial Details

Completed

A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplasia

NCT00580242

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +5 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia

NCT00677859

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +12 more
Locations: Mayo Clinic Hospital Phoenix, Arizona, United States

University Hospitals Case Medical Center Cleveland, Ohio, United States

Oregon State University Medical Center Portland, Oregon, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT00721864

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +15 more
Locations: University of Utah Salt Lake City, Utah, United States

View Trial Details

Completed

Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia

NCT00136422

Conditions: Acute Myelogenous Leukemia, Anemia, Anemia, Refractory, +11 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients

NCT00195533

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +19 more
Locations: A Coruña, Spain

Alcalá de Henares, Spain

Alzira, Spain

Barcelona, Spain

View Trial Details

Completed

A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies

NCT00506402

Conditions: Agnogenic Myeloid Metaplasia, Anemia, Anemia, Refractory, +12 more
Locations: Princess Margaret Hospital Toronto, Canada

View Trial Details

Completed

Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT

NCT00516152

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Advanced Myeloproliferative Disease, +41 more
Locations: University of California San Francisco San Francisco, California, United States

View Trial Details

Completed

Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria

NCT00098280

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +4 more
Locations: National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States

View Trial Details

Completed

Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT00039923

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +8 more
Locations: National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States

View Trial Details